Ceftriaxone (Rocephin) is the preferred choice for intramuscular treatment of cat bites
For cat bite wounds requiring IM antibiotic therapy, ceftriaxone 1g IM every 12-24 hours is recommended over cefazolin. This is based on the IDSA guidelines which specifically list ceftriaxone as an appropriate third-generation cephalosporin for animal bite infections, while cefazolin is notably absent from the animal bite treatment recommendations 1.
Rationale Based on Microbiology
Cat bites have a uniquely high infection risk (20-80% become infected) primarily due to Pasteurella multocida, which is carried in approximately 90% of cats' oral cavities and is isolated in over half of all infected cat bite wounds 2, 3. The key microbiologic considerations are:
- Ceftriaxone provides excellent coverage against P. multocida, the predominant pathogen in cat bites 1
- Cefazolin has poor activity against P. multocida despite 98% susceptibility in one study 2, and is specifically noted to "miss anaerobes" in the IDSA guidelines
- The IDSA guidelines list ceftriaxone (1g every 12h IV/IM) under third-generation cephalosporins for animal bites, while second-generation cephalosporins like cefuroxime are noted to have "good activity against P. multocida but miss anaerobes" 1
Practical Dosing
Adults: Ceftriaxone 1 gram IM every 12-24 hours 1, 4
Pediatric patients: 50-75 mg/kg/day for skin and soft tissue infections (not to exceed 2 grams daily) 4
Important Caveats
- Hand bites carry the highest infection risk and warrant aggressive treatment 3
- Ceftriaxone is contraindicated in neonates ≤28 days receiving calcium-containing IV solutions 4
- While amoxicillin-clavulanate remains the first-line oral agent for cat bites 1, when IM therapy is specifically needed (patient unable to take oral medications, compliance concerns, or severe infection), ceftriaxone is superior to cefazolin
- Cefazolin is not listed in the IDSA animal bite treatment table, appearing only in the general antimicrobial dosing tables for staphylococcal coverage 1
Why Not Cefazolin?
Although cefazolin has been studied for skin and soft tissue infections 5 and shows equivalence to ceftriaxone in some contexts 6, the specific pathogen profile of cat bites makes it inappropriate. The IDSA guidelines' omission of first-generation cephalosporins from animal bite recommendations is deliberate, as these agents lack adequate coverage for the polymicrobial flora (including anaerobes and P. multocida) characteristic of cat bite infections 1.